Optimal Embryonic Stage for Transfer in Poor Responders

NCT ID: NCT04485819

Last Updated: 2020-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Prospective cohort study including couples with poor responder females who undergoing ICSI

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose:

To determine the optimal embryonic stage for transfer in poor responders.

Method:

Patients were divided into day 3 transfer group and day 5 transfer group. All cases had the same stimulation protocol and planning to do fresh embryo transfer. Assessments will be at Day 1, Day 3 and Day 5/6 according to Gardner's criteria 1999. Embryological and clinical data were recorded and then analyzed using SPSS (version 23) statistical software.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Poor Response to Ovulation Induction Infertility, Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cleavage stage transfer

Poor responders who transfer their embryos in cleavage stage on day 3

Cleavage stage transfer

Intervention Type OTHER

transferring embryos through ICSI procedures for poor responders on cleavage stage of embryonic development.

Blast stage transfer

Poor responders who transfer their embryos on blast stage on day 5/6

Blast stage transfer

Intervention Type OTHER

transferring embryos through ICSI procedures for poor responders on blast stage of embryonic development.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cleavage stage transfer

transferring embryos through ICSI procedures for poor responders on cleavage stage of embryonic development.

Intervention Type OTHER

Blast stage transfer

transferring embryos through ICSI procedures for poor responders on blast stage of embryonic development.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* poor responders females with AMH≤ 1.2ng and have ≤ 5 mature oocytes
* couples whose planning to do fresh transfer
* male partners have normal semen parameters according to WHO 2010.

Exclusion Criteria

* sperm or oocyte donation
* gestational carriers
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ganin Fertility Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manar Hozyen, MSc.

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Amira Hassan, BSc.

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Hanaa Elkhader, BSc.

Role: PRINCIPAL_INVESTIGATOR

Ganin Fertility Center

Hosam Zaki

Role: STUDY_CHAIR

Ganin Fertility Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ganin fertility center

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Manar M Hozyen, MSc.

Role: CONTACT

+2001229483320

Amira Hassan, BSc.

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MH0003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.